HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Retinal tumor imaging and volume quantification in mouse model using spectral-domain optical coherence tomography.

Abstract
We have successfully imaged the retinal tumor in a mouse model using an ultra-high resolution spectral-domain optical coherence tomography (SD-OCT) designed for small animal retinal imaging. For segmentation of the tumor boundaries and calculation of the tumor volume, we developed a novel segmentation algorithm. The algorithm is based on parametric deformable models (active contours) and is driven by machine learning-based region classification, namely a Conditional Random Field. With this algorithm we are able to obtain the tumor boundaries automatically, while the user can specify additional constraints (points on the boundary) to correct the segmentation result, if needed. The system and algorithm were successfully applied to studies on retinal tumor progression and monitoring treatment effects quantitatively in a mouse model of retinoblastoma.
AuthorsMarco Ruggeri, Gavriil Tsechpenakis, Shuliang Jiao, Maria Elena Jockovich, Colleen Cebulla, Eleut Hernandez, Timothy G Murray, Carmen A Puliafito
JournalOptics express (Opt Express) Vol. 17 Issue 5 Pg. 4074-83 (Mar 02 2009) ISSN: 1094-4087 [Electronic] United States
PMID19259247 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Cinnamates
  • Luteinizing Hormone, beta Subunit
  • SU 1498
  • Vascular Endothelial Growth Factor Receptor-2
Topics
  • Algorithms
  • Animals
  • Cinnamates (pharmacology)
  • Disease Models, Animal
  • Image Processing, Computer-Assisted
  • Luteinizing Hormone, beta Subunit (genetics)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Transgenic
  • Retinal Neoplasms (drug therapy, etiology, pathology)
  • Retinoblastoma (drug therapy, etiology, pathology)
  • Tomography, Optical Coherence (methods, statistics & numerical data)
  • Vascular Endothelial Growth Factor Receptor-2 (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: